Résultats de la recherche - 6 results
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017
Lyytikäinen, Outi; Reilly, Jacqui; Aleksander Deptula; Walter Zingg; Plachouras, Diamantis; Dominique L Monnet; the Healthcare-Associated Infections Prevalence Study Group; Eline Vandael; Boudewijn Catry Source: ...
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
Zingg; Pete Kinross; Klaus Weist; Dominique L. Monnet; Suetens, Carl; the Point Prevalence Survey Study Group; Katrien Latour; Eline Vandael Source: Eurosurveillance, Volume 23, Issue 46 (2018) Keywords: ...
Characteristics of the antibiotic regimen that affect antimicrobial resistance in urinary pathogens
is unclear. Methods In this retrospective multi-center cohort study, we assessed the impact of different variables on antimicrobial resistance (AMR) in pathogens isolated from the urinary tract in older adults. ...
Poor adherence to guidelines for preventing central line-associated bloodstream infections (CLABSI): results of a worldwide survey.
CLABSI rate. Heterogeneity between countries was high and country specific results are made available. CONCLUSIONS: This study has identified areas for improvement in CLABSI prevention practices linked to ...
Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review.
molecular markers analysed and polymorphisms detected. RESULTS: Thirteen articles were included and five genes have been analysed in these studies: pfcrt, pfdhps, pfdhfr, pfmdr1 and K13-propeller. The ...
The search for therapeutic bacteriophages uncovers one new subfamily and two new genera of Pseudomonas-infecting Myoviridae.
Abstract: In a previous study, six virulent bacteriophages PAK_P1, PAK_P2, PAK_P3, PAK_P4, PAK_P5 and CHA_P1 were evaluated for their in vivo efficacy in treating Pseudomonas aeruginosa infections using ...